FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149969425> ?p ?o ?g. }

• W2149969425 endingPage "193" @default.
• W2149969425 startingPage "186" @default.
• W2149969425 abstract "γ-Vinyl-γ-aminobutyric acid (GVG) elevates central nervous system γ-aminobutyric acid (GABA) levels by irreversibly inhibiting GABA transaminase. An open-label clinical trial in humans suggested that GVG may reduce cocaine and methamphetamine use. To test safety and to obtain preliminary data on efficacy of GVG for treating methamphetamine dependence, we conducted a double-blind, placebo-controlled, parallel group study of GVG interaction with the cardiovascular and subjective effects produced by methamphetamine. Non-treatment seeking methamphetamine-dependent volunteers received either GVG (N = 8) or placebo (N = 9) by random assignment. GVG treatment was initiated at 1 g/day and increased to 5 g/day. After reaching the target dose of 5 g/day, participants received methamphetamine (15 + 30 mg, IV), and cardiovascular and subjective effects were assessed. No serious adverse events were noted, and the total number of adverse events was similar between the treatment groups. Considering the full time course and peak effects independently, no significant differences were detected between the groups for systolic or diastolic blood pressures, or heart rate, following methamphetamine exposure. Some methamphetamine-induced cardiovascular changes approached significance (p < 0.10) and may warrant attention in future trials. Methamphetamine-induced subjective effects (“any drug effect”, “high”, “crave methamphetamine”) were statistically similar between GVG and placebo treatment groups. Pharmacokinetic data indicate that GVG treatment did not alter methamphetamine or amphetamine plasma levels, and there was no association between methamphetamine or amphetamine plasma levels and peak cardiovascular effects. Taken together, the data indicate that GVG treatment is generally well tolerated but not efficacious in attenuating the positive subjective effects of methamphetamine in the laboratory." @default.
• W2149969425 created "2016-06-24" @default.
• W2149969425 creator A5016497110 @default.
• W2149969425 creator A5019337347 @default.
• W2149969425 creator A5030381992 @default.
• W2149969425 creator A5031442075 @default.
• W2149969425 creator A5040464938 @default.
• W2149969425 creator A5059600880 @default.
• W2149969425 creator A5068139431 @default.
• W2149969425 creator A5079026897 @default.
• W2149969425 date "2009-11-01" @default.
• W2149969425 modified "2023-10-17" @default.
• W2149969425 title "The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers" @default.
• W2149969425 cites W1963849023 @default.
• W2149969425 cites W1964151041 @default.
• W2149969425 cites W1980046175 @default.
• W2149969425 cites W1981103739 @default.
• W2149969425 cites W1982554516 @default.
• W2149969425 cites W1987931229 @default.
• W2149969425 cites W1995002642 @default.
• W2149969425 cites W1995658531 @default.
• W2149969425 cites W2003320100 @default.
• W2149969425 cites W2003590685 @default.
• W2149969425 cites W2006803692 @default.
• W2149969425 cites W2007221331 @default.
• W2149969425 cites W2008780594 @default.
• W2149969425 cites W2011963599 @default.
• W2149969425 cites W2014061405 @default.
• W2149969425 cites W2024007792 @default.
• W2149969425 cites W2024501939 @default.
• W2149969425 cites W2025220390 @default.
• W2149969425 cites W2026785985 @default.
• W2149969425 cites W2040276248 @default.
• W2149969425 cites W2045126331 @default.
• W2149969425 cites W2049743610 @default.
• W2149969425 cites W2062542275 @default.
• W2149969425 cites W2066990175 @default.
• W2149969425 cites W2067923443 @default.
• W2149969425 cites W2072636618 @default.
• W2149969425 cites W2072862951 @default.
• W2149969425 cites W2077616658 @default.
• W2149969425 cites W2079763422 @default.
• W2149969425 cites W2082711546 @default.
• W2149969425 cites W2102842111 @default.
• W2149969425 cites W2104314642 @default.
• W2149969425 cites W2129865459 @default.
• W2149969425 cites W2155133471 @default.
• W2149969425 cites W2160932229 @default.
• W2149969425 cites W2161047816 @default.
• W2149969425 cites W2165479128 @default.
• W2149969425 doi "https://doi.org/10.1016/j.pbb.2009.08.007" @default.
• W2149969425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2775447" @default.
• W2149969425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19698734" @default.
• W2149969425 hasPublicationYear "2009" @default.
• W2149969425 type Work @default.
• W2149969425 sameAs 2149969425 @default.
• W2149969425 citedByCount "17" @default.
• W2149969425 countsByYear W21499694252012 @default.
• W2149969425 countsByYear W21499694252013 @default.
• W2149969425 countsByYear W21499694252014 @default.
• W2149969425 countsByYear W21499694252015 @default.
• W2149969425 countsByYear W21499694252016 @default.
• W2149969425 countsByYear W21499694252019 @default.
• W2149969425 countsByYear W21499694252020 @default.
• W2149969425 countsByYear W21499694252021 @default.
• W2149969425 countsByYear W21499694252022 @default.
• W2149969425 crossrefType "journal-article" @default.
• W2149969425 hasAuthorship W2149969425A5016497110 @default.
• W2149969425 hasAuthorship W2149969425A5019337347 @default.
• W2149969425 hasAuthorship W2149969425A5030381992 @default.
• W2149969425 hasAuthorship W2149969425A5031442075 @default.
• W2149969425 hasAuthorship W2149969425A5040464938 @default.
• W2149969425 hasAuthorship W2149969425A5059600880 @default.
• W2149969425 hasAuthorship W2149969425A5068139431 @default.
• W2149969425 hasAuthorship W2149969425A5079026897 @default.
• W2149969425 hasBestOaLocation W21499694252 @default.
• W2149969425 hasConcept C126322002 @default.
• W2149969425 hasConcept C142724271 @default.
• W2149969425 hasConcept C15744967 @default.
• W2149969425 hasConcept C204787440 @default.
• W2149969425 hasConcept C27081682 @default.
• W2149969425 hasConcept C2777193897 @default.
• W2149969425 hasConcept C2780376393 @default.
• W2149969425 hasConcept C42219234 @default.
• W2149969425 hasConcept C513476851 @default.
• W2149969425 hasConcept C71924100 @default.
• W2149969425 hasConcept C98274493 @default.
• W2149969425 hasConceptScore W2149969425C126322002 @default.
• W2149969425 hasConceptScore W2149969425C142724271 @default.
• W2149969425 hasConceptScore W2149969425C15744967 @default.
• W2149969425 hasConceptScore W2149969425C204787440 @default.
• W2149969425 hasConceptScore W2149969425C27081682 @default.
• W2149969425 hasConceptScore W2149969425C2777193897 @default.
• W2149969425 hasConceptScore W2149969425C2780376393 @default.
• W2149969425 hasConceptScore W2149969425C42219234 @default.
• W2149969425 hasConceptScore W2149969425C513476851 @default.
• W2149969425 hasConceptScore W2149969425C71924100 @default.
• W2149969425 hasConceptScore W2149969425C98274493 @default.

• next